Home › Hemoglobinopathies
Pag-aaral pangklinika para sa Hemoglobinopathies na nagre-recruit sa U.S.
14 pag-aaral para sa Hemoglobinopathies ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- St. Louis, MO4 pag-aaral
- New York City, NY4 pag-aaral
- Philadelphia, PA3 pag-aaral
- Nashville, TN3 pag-aaral
- Memphis, TN3 pag-aaral
- Minneapolis, MN3 pag-aaral
Ayos sa estado
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06313398Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Nagre-recruitPhase 1/2
Hanggang edad 20 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT00920972Long Term Follow-Up Study for Individuals With Hemoglobin Disorders After Hematopoietic Cell Transplant or Gene Therapy
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06646640The HOPE Biobank Resource (BMT CTN 2402 HOPE)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07227155Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Nagre-recruit
Hanggang edad 55 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01666080TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
Nagre-recruitPhase 2
Edad 0 hanggang 21 · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT04356469Allo HSCT for High Risk Hemoglobinopathies
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Hanggang edad 55 · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT06872333Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Nagre-recruitPhase 1/2
1 Day – 21 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT03128996Discarded Bone Marrow for Hematology Research
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update May 5, 2026 · NCT04671212Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Nagre-recruitPhase 1/2
1 Month – 25 Years · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT06839456Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Nagre-recruitPhase 3
Edad 12 hanggang 35 · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT05477563Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
Nagre-recruitPhase 2
Hanggang edad 21 · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT04644016A Long-term Follow-up Study in Patients Who Received BEAM-101
Nagre-recruitObservasyonal na pag-aaral
Edad 14 hanggang 37 · Lahat ng kasarian · Na-update Ene 28, 2026 · NCT07373639Study of the Role of Genetic Modifiers in Hemoglobinopathies
Nagre-recruitObservasyonal na pag-aaral
Edad 2 pataas · Lahat ng kasarian · Na-update Mar 20, 2024 · NCT05799118Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.